Analystreport

Akero Therapeutics, Inc. (NASDAQ: AKRO) had its "outperform" rating re-affirmed by analysts at Lifesci Capital.

Akero Therapeutics, Inc.  (AKRO) 
Last akero therapeutics, inc. earnings: 3/16 07:30 am Check Earnings Report